CTOs on the Move

Smith and Nephew

www.smith-nephew.com

 
Smith & Nephew is a global advanced medical technology business. We support healthcare professionals in more than 100 countries to improve the quality of life for their patients. Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions. Through our market leadership positions in Sports Medicine, Trauma, Orthopaedic Reconstruction and Advanced Wound Management, our 16,000 employees continue to improve outcomes and expand access, constantly striving to create ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
David Bradley
Sr. IT Director, Global Operations Profile
Michael Groskopf
VP CIO, Orthopaedics & ENT Profile
Jody Jenkins
Director of Global Information Security Profile
Nick Gerteisen
Senior Director, Global Product Security Profile
Nick Gerteisen
Deputy Chief Information Security Profile

Similar Companies

Neopenda

At Neopenda, we believe that the most vulnerable patient populations in the world deserve access to high quality health care. We re a social enterprise startup passionate about improving newborn health through innovative technology solutions, and implementing them sustainably in emerging markets. Neopendas first product is a scalable wireless vital signs monitor for patients in overcrowded, understaffed health facilities. Our solution reduces response time to newborns in distress, and helps healthcare workers to save more lives. We are currently validating our technology in clinical studies with our partners in Uganda.

HR Pharmaceuticals

HR Pharmaceuticals, Inc. is a Delaware registered corporation headquartered in York, Pennsylvania. Owner of the two (2) legacy brands of surgical lubricant: Surgilube & HR Lubricating Jelly; the standard in the medical community for over 85 years. Since the inception of HR Pharma in 2008 we have developed a reputation of quality, safety and value; these same principles date back to 1931 of producing quality products that benefit mankind. With Manufacturing Integrity and 100% compliance to ISO 9001:2008, ISO 13485:2003, cGMP requirements and the Orthodox Union, HR® creates value for our customers by continuously delivering safe and effective medical devices, pharmaceuticals & other consumer products. HR is one of central PA`s fastest growing companies. We have increased our product offering by 2000% since 2011, and are continuing this growth into 2016. We take pride in offering quality, affordable, and American made products and will continue to develop new products based on this philosophy. We emphasize a vibrant and non-bureaucratic culture which we believe has formed our meaningful and productive team.

Medtap International

Medtap International is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Applied Medical Resources Corporation

Applied Medical has developed strategic partnerships with a number of top research institutions and medical industry pioneers. The surgical equipment market is diverse and complex. Applied Medical is committed to working with our partners to provide

Transgenomic

Transgenomic is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events.  Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.